Yale Bulletin and Calendar

November 18, 2005|Volume 34, Number 12|Two-Week Issue


BULLETIN HOME

VISITING ON CAMPUS

CALENDAR OF EVENTS

IN THE NEWS

BULLETIN BOARD

CLASSIFIED ADS


SEARCH ARCHIVES

DEADLINES

DOWNLOAD FORMS

BULLETIN STAFF


PUBLIC AFFAIRS HOME

NEWS RELEASES

E-MAIL US


YALE HOME PAGE


Dr. David Fiellin receives support for
research on treatment of substance abuse

Dr. David A. Fiellin, associate professor of medicine, has received over $3 million in grants from the National Institutes of Health and the Robert Wood Johnson Foundation to advance his research on substance abuse.

The National Institute of Drug Abuse awarded Fiellin $2.9 million over five years to support the study "Counseling for Primary Care Office-Based Buprenorphine." His five-year study will evaluate whether on-site cognitive behavioral therapy drug counseling coupled with routine physician counseling will lead to increased adherence to buprenorphine treatment and reduced illicit drug use.

"The results of this study will help define the role of professional evidence-based drug counseling in the effort to expand access to treatment with buprenorphine," says Fiellin.

Fiellin also received a grant from the Robert Wood Johnson Foundation to investigate state Medicaid and public funding for buprenorphine treatment.

Fiellin will receive the Nyswander-Dole Award from the American Association of the Treatment of Opioid Dependence (AATOD) in April. The award recognizes extraordinary work and service in the field of opioid treatment.

AATOD was founded in 1984 to enhance the quality of patient care in treatment programs by promoting the growth and development of comprehensive methadone treatment services throughout the United States.

Fiellin's work is focused on the recognition and treatment of substance abuse disorders in office-based, primary care and HIV specialty settings. He has studied primary care opioid agonist treatment, quality of care for patients with alcohol problems and prognostic factors in alcohol withdrawal syndrome. His studies examine strategies for primary care and HIV specialty-based opioid agonist treatment with buprenorphine.


T H I SW E E K ' SS T O R I E S

Yale will build new child care center as part of family-oriented initiatives

Professor, alumni receive National Humanities Medals

Study links strokes and common sleep disorder

Women's soccer team wins Ivy crown, makes NCAA 'Sweet 16'

Dr. David Fiellin receives support for research . . .

ENDOWED PROFESSORSHIPS

Yale scientists discover way to predict microstructure of crystals

Study finds that regular practice of meditation . . .

Grant to fund study of tics and Tourette syndrome

Yale veterans' sacrifices in service to their country honored

Study to explore effects of cholesterol drug on heart patients

Ceremony celebrates recent Davenport College renovations

Woolsey Hall Live

Yale awards fellowships to junior faculty

Production will take a new look at Shakespeare's most famous play

Newly created conference honors former dean of School of Nursing

Six members of the engineering faculty win awards . . .

Students will vie in simulated court cases . . .

Doctoral students, alumna win Gilder Lehrman Fellowships

Five former Yale athletes are lauded for their leadership

Campus Notes


Bulletin Home|Visiting on Campus|Calendar of Events|In the News

Bulletin Board|Classified Ads|Search Archives|Deadlines

Bulletin Staff|Public Affairs|News Releases| E-Mail Us|Yale Home